Immune response to melanoma

Israeli oncology treatment developer cCam Medical Ltd has developed CM-10, an immune-modulating antibody, whose anticancer effect has been demonstrated in multiple pre-clinical tests. cCam has just raised $3million to fund further trials.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *